Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 19.

Roche's RoACTEMRA receives EU approval for use in patients with early rheumatoid arthritis (RA)
Roche announced today that RoACTEMRA (tocilizumab) has received approval from the European Commission for use in patients with severe, active and progressive RA who previously have not been treated with methotrexate (MTX). Treating the disease at this critical early phase may prevent irreversible damage to joints and long-term disability.1,2 RoACTEMRA is the first interleukin-6 (IL-6) receptor antagonist to be approved for use in Europe in patients with early RA. (Source: Roche Media News)
Source: Roche Media News - September 8, 2014 Category: Pharmaceuticals Source Type: news

Roche's RoACTEMRA receives EU approval for use in patients with early rheumatoid arthritis (RA)
Roche announced today that RoACTEMRA (tocilizumab) has received approval from the European Commission for use in patients with severe, active and progressive RA who previously have not been treated with methotrexate (MTX). Treating the disease at this critical early phase may prevent irreversible damage to joints and long-term disability. RoACTEMRA is the first interleukin-6 (IL-6) receptor antagonist to be approved for use in Europe in patients with early RA. (Source: Roche Investor Update)
Source: Roche Investor Update - September 8, 2014 Category: Pharmaceuticals Source Type: news

RheumShorts: HCV Complicates RA Treatment, Outcomes (CME/CE)
(MedPage Today) -- New studies examined the effects of hepatitis C virus infection in patients with rheumatoid arthritis and socioeconomic status on juvenile idiopathic arthritis, and a report from Finland traced an outbreak of foodborne disease and reactive arthritis. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - September 5, 2014 Category: Geriatrics Source Type: news

RA: Effect of 'Complete Disease Control' on Pain, FunctionRA: Effect of 'Complete Disease Control' on Pain, Function
Patients with rheumatoid arthritis who have more complete disease control had better outcomes than those who did not. Medscape Medical News (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - September 4, 2014 Category: Rheumatology Tags: Rheumatology News Source Type: news

Many Rheumatoid Arthritis Patients May Skip Meds: Study
Title: Many Rheumatoid Arthritis Patients May Skip Meds: StudyCategory: Health NewsCreated: 9/3/2014 5:35:00 PMLast Editorial Review: 9/4/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 4, 2014 Category: Rheumatology Source Type: news

Many Rheumatoid Arthritis Patients May Skip Meds: Study
This could lead to worsening of symptoms, researchers say (Source: WebMD Health)
Source: WebMD Health - September 3, 2014 Category: Consumer Health News Source Type: news

Treat-to-Target With Actemra Succeeds in RA
(MedPage Today) -- Treating rheumatoid arthritis with tocilizumab (Actemra) only until remission was achieved allowed many patients to achieve sustained remission, and some were able to stop treatment altogether for short periods. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - September 3, 2014 Category: Primary Care Source Type: news

Many Rheumatoid Arthritis Patients May Skip Meds
This could lead to worsening of symptoms, researchers say Source: HealthDay Related MedlinePlus Pages: Medicines, Rheumatoid Arthritis (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - September 3, 2014 Category: Consumer Health News Source Type: news

How to Get in the Mood for Sex When You Have RA
If you have rheumatoid arthritis, sex can ease pain, lift your spirits, and keep you connected to your partner. So don't avoid sex -- just take a little extra care to make it feel good. Here's how. (Source: WebMD Health)
Source: WebMD Health - September 3, 2014 Category: Consumer Health News Source Type: news

Rheumatoid Arthritis: Test Your Arthritis IQ
Title: Rheumatoid Arthritis: Test Your Arthritis IQCategory: MedicineNet QuizCreated: 1/31/2011 5:38:00 PMLast Editorial Review: 9/3/2014 12:49:27 PM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - September 3, 2014 Category: Rheumatology Source Type: news

RA: Publication Bias Alive and Well
(MedPage Today) -- Randomized trials of treatments for rheumatoid arthritis with positive outcomes have remained more likely to be published than those with negative results, despite the establishment of ClinicalTrials.gov. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - August 28, 2014 Category: American Health Source Type: news

Rheumatoid Arthritis: Living With a Chronic Disease
Title: Rheumatoid Arthritis: Living With a Chronic DiseaseCategory: Doctor's & Expert's views on SymptomsCreated: 1/19/2012 7:09:00 PMLast Editorial Review: 8/28/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 28, 2014 Category: Rheumatology Source Type: news

Patient Story: Rheumatoid Arthritis Treatment
Title: Patient Story: Rheumatoid Arthritis TreatmentCategory: Doctor's & Expert's views on SymptomsCreated: 1/20/2012 7:03:00 PMLast Editorial Review: 8/28/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 28, 2014 Category: Rheumatology Source Type: news

Cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis
Two psychological interventions have been separately and in combination been studied to determine their effectiveness in offering relief to RA patients. Cognitive-behavioral coping skills training trains patients in various cognitive and behavioral techniques or skills to enhance their ability to cope with pain and improve their behavioral and psychological functioning. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 23, 2014 Category: Science Source Type: news

Creating pomegranate drug to stem Alzheimer's, Parkinson's
Research will look to produce compound derivatives of punicalagin for a drug that would treat neuro-inflammation and slow down the progression of Alzheimer's disease, scientists report. The onset of Alzheimer's disease can be slowed and some of its symptoms curbed by a natural compound that is found in pomegranate. Also, the painful inflammation that accompanies illnesses such as rheumatoid arthritis and Parkinson's disease could be reduced, according to the findings of the two-year project. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 22, 2014 Category: Science Source Type: news

Research underway to create pomegranate drug to stem Alzheimer's and Parkinson's
(University of Huddersfield) The onset of Alzheimer's disease can be slowed and some of its symptoms curbed by a natural compound that is found in pomegranate. Also, the painful inflammation that accompanies illnesses such as rheumatoid arthritis and Parkinson's disease could be reduced, according to the findings of a two-year project headed by University of Huddersfield scientist Dr. Olumayokun Olajide, who specialises in the anti-inflammatory properties of natural products. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2014 Category: Global & Universal Source Type: news

Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis
(Wayne State University - Office of the Vice President for Research) A team of researchers from Wayne State University and collaborators from Duke University Medical Center recently published a paper in the Journal of Consulting and Clinical Psychology that explores two psychological interventions separately and in combination to determine their effectiveness in offering relief to rheumatoid arthritis patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 22, 2014 Category: Global & Universal Source Type: news

RheumShorts: Allipurinol, Autoantibodies in RA (CME/CE)
(MedPage Today) -- The rheumatology literature this week featured studies on allopurinol and severe cutaneous adverse reactions, the additive effects of autoantibodies on bone erosions in rheumatoid arthritis, and predicting response to methotrexate in children with juvenile idiopathic arthritis. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 20, 2014 Category: Primary Care Source Type: news

RheumShorts: Allopurinol; Autoantibodies in RA (CME/CE)
(MedPage Today) -- The rheumatology literature this week featured studies on allopurinol and severe cutaneous adverse reactions, the additive effects of autoantibodies on bone erosions in rheumatoid arthritis, and predicting response to methotrexate in children with juvenile idiopathic arthritis. (Source: MedPage Today Rheumatology)
Source: MedPage Today Rheumatology - August 20, 2014 Category: Rheumatology Source Type: news

BrCa Risk Stable With Anti-TNF Tx
(MedPage Today) -- Women with rheumatoid arthritis and a history of breast cancer had no increased risk of cancer recurrence if treated with anti-tumor necrosis factor therapy, Swedish researchers reported. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - August 18, 2014 Category: Geriatrics Source Type: news

TNF Inhibitors for RA: No Link to Breast CancerTNF Inhibitors for RA: No Link to Breast Cancer
Swedish researchers have found no link between TNF inhibitors used to treat rheumatoid arthritis and breast cancer recurrence. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 18, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Response to Rituximab in RA Not Altered by StatinsResponse to Rituximab in RA Not Altered by Statins
Statins do not appear to alter the response to rituximab significantly in patients with rheumatoid arthritis, according to new research. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 15, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

National Psoriasis Foundation on Improving the Lives of Patients
Millions of Americans with psoriatic arthritis—a serious disease that causes pain, swelling and stiffness of the joints and tendons, and can result in joint damage if left untreated—struggle to get the health care and treatments they need to manage their condition. National Psoriasis Foundation plans to change with the largest realignment and expansion of its psoriatic arthritis program. For nearly two decades, the Psoriasis Foundation has provided disease-management services and information to people with psoriatic arthritis (PsA), which affects as many as one in three people with psoriasis, the most common autoimmune...
Source: PHRMA - August 13, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Understanding Rheumatoid Arthritis Medications
Rheumatoid Arthritis Medications (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - August 13, 2014 Category: Journals (General) Source Type: news

Mayo Clinic News Network — Headlines 8/13/14
http://youtu.be/jZe10TqaOoI Mayo Clinic News Network Headlines include: Prescription drugs online Early diagnosis of rheumatoid arthritis Choosing sunscreen Journalists: Video is available in the downloads. Click here for script. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 13, 2014 Category: Databases & Libraries Source Type: news

'Worm pill' could ease autoimmune disease symptoms
Experts believe a molecule in parasitic worms could help explain why worm infections can effectively treat a range of autoimmune diseases, including multiple sclerosis, psoriasis, rheumatoid arthritis and lupus. The study successfully identified peptides from parasitic worms that suppress the body's immune response. Researchers believe this could pave the way for a new drug containing the peptide to provide relief from the symptoms of autoimmune diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 11, 2014 Category: Science Source Type: news

RheumShorts: IL-6 and RA, Life and Death, Surgery in Lupus (CME/CE)
(MedPage Today) -- The September issue of the Annals of the Rheumatic Diseases featured studies on an investigational interleukin-6 inhibitor for rheumatoid arthritis, mortality effects of early remission in inflammatory arthritis, and adverse surgical outcomes for patients with lupus. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - August 6, 2014 Category: Geriatrics Source Type: news

Toward Personalized Medicine for Kidney Transplant Recipients
UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective in improving and maintaining the long-term health of kidney transplant recipients. (Source: UCSF Medical Center)
Source: UCSF Medical Center - August 5, 2014 Category: Universities & Medical Training Authors: webservices at ucsfhealth.org Source Type: news

Gabriela Lavezzari on Improving the Lives of Patients with Arthritis
Many people are unaware of the impact of arthritis and related musculoskeletal diseases in the United States. They affect approximately 52.5 million Americans of all ages, races and genders. The biopharmaceutical industry is making great strides towards new treatments with 92 medicines in the pipeline which have the potential to help patients live more active and productive lives. Work on these treatments is more imperative than ever as 67 million people could be diagnosed with some form of musculoskeletal disease by 2030, according to the U.S. Centers for Disease Control and Prevention. Earlier this year, PhRMA joined 10...
Source: PHRMA - August 4, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Toward personalized medicine for kidney transplant recipients
(University of California - San Francisco) UC San Francisco is the lead institution on a new seven-year, $17 million multicenter study funded by the National Institutes of Health to determine if certain immune system cells and/or a drug now used for treating rheumatoid arthritis can be effective in improving and maintaining the long-term health of kidney transplant recipients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 4, 2014 Category: Global & Universal Source Type: news

Prevalence of falls in fibromyalgia patients - Meireles SA, Antero DC, Kulczycki MM, Skare TL.
OBJECTIVE: To compare the risk of falls in fibromyalgia (FM) patients compared to rheumatoid arthritis (RA) patients and normal controls. METHODS: We studied 60 FM, 60 RA patients and 60 controls for fall frequency in one week, one month, six month... (Source: SafetyLit: All (Unduplicated))
Source: SafetyLit: All (Unduplicated) - August 3, 2014 Category: Global & Universal Tags: Falls Source Type: news

Obesity in Women Linked With Early RA
(MedPage Today) -- Women who are overweight or obese, particularly those becoming so by late adolescence, have an elevated risk for developing rheumatoid arthritis. (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - August 1, 2014 Category: Endocrinology Source Type: news

Frontier Pharma Rheumatoid Arthritis Identifying and Commercializing...
Market Resarch Reports.Biz include new market research report "Frontier Pharma - Rheumatoid Arthritis: Identifying and Commercializing First-in-Class Innovation" to its huge collection of...(PRWeb July 30, 2014)Read the full story at http://www.prweb.com/releases/2014/07/prweb12047446.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 31, 2014 Category: Pharmaceuticals Source Type: news

RheumShorts: MRI in RA, Fostamatinib, Statins and Rituximab (CME/CE)
(MedPage Today) -- Studies this week in Annals of the Rheumatic Diseases highlighted the potential role for MRI in predicting progression in early rheumatoid arthritis (RA), negative results with fostamatinib, and the use of statins among patients taking rituximab (Rituxan). (Source: MedPage Today Psychiatry)
Source: MedPage Today Psychiatry - July 31, 2014 Category: Psychiatry Source Type: news

Stephen I. Katz on Improving the Lives of Patients with Arthritis
To improve the lives of people with arthritis, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is working toward a better understanding of the basic biology of diseases affecting the joints, better diagnosis and treatment of arthritis, and better tools to facilitate clinical trials. NIAMS was a key contributor to the development of tofacitinib, the first oral disease modifying antirheumatic drug (DMARD) for rheumatoid arthritis (RA) in a decade, which recently received  approval from the U.S. Food and Drug Administration. In the early 1990’s, NIAMS intramural researchers discovered Janu...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Amanda Niskar on Improving the Lives of Patients with Arthritis
For almost 70 years, the Arthritis Foundation has initiated and supported scientific discoveries that improve health outcomes for people with arthritis. Research holds the key to finding better diagnostics and treatments—and one day a cure—for more than 50 million Americans who face the daily challenges of arthritis. At the Foundation, we are focused on providing scientific leadership and direction to improve everyday life for people with arthritis and to find a cure.   Information from the Medicines in Development report issued by the Pharmaceutical Research Manufacturers of America (PhRMA), about medicines that are ...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Early Diagnosis and Aggressive Approach to Rheumatoid Arthritis
https://www.youtube.com/watch?v=FloX45Ue414 Being diagnosed with rheumatoid arthritis can be frightening. It's a lifelong chronic condition that not only causes painful damage to your joints but can affect other areas of the body, including heart and kidneys. So, an early diagnosis and an aggressive approach to treatment can mean having much better control of the disease. [TRT 2:35] [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 30, 2014 Category: Databases & Libraries Source Type: news

Minor Changes in Kidney Function With RA Drug
(MedPage Today) -- Slight increases in serum creatinine levels were seen in a small number of rheumatoid arthritis patients treated with tofacitinib (Xeljanz) in phase III trials, but the clinical significance of the finding is uncertain. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - July 29, 2014 Category: Geriatrics Source Type: news

Christopher F. Smith on Improving the Lives of Patients
Like PhRMA, improving the lives of people with arthritis is one of the cornerstones of the mission of the Arthritis Foundation.   The Foundation achieves this mission in several ways including help and support for people with arthritis, advocacy and access to critical medications, and research. Every day thousands of individuals with arthritis seek answers to a myriad of questions about this chronic, debilitating and incurable disease.   And they will seek those answers tomorrow, next week, next month and next year and beyond. As a 24/7 resource, the Arthritis Foundation is ready to provide answers.   In response to PhR...
Source: PHRMA - July 29, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Christopher F. Smith on Improving the Lives of Patients with Arthritis
Like PhRMA, improving the lives of people with arthritis is one of the cornerstones of the mission of the Arthritis Foundation.   The Foundation achieves this mission in several ways including help and support for people with arthritis, advocacy and access to critical medications, and research. Every day thousands of individuals with arthritis seek answers to a myriad of questions about this chronic, debilitating and incurable disease.   And they will seek those answers tomorrow, next week, next month and next year and beyond. As a 24/7 resource, the Arthritis Foundation is ready to provide answers.   In response to PhR...
Source: PHRMA - July 29, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Roche's RoACTEMRA receives CHMP positive opinion in Europe for use in patients with early rheumatoid arthritis (RA) not previously treated with methotrexate (MTX)
Roche announced today that RoACTEMRA (tocilizumab, also known as ACTEMRA) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for use in Europe in patients not previously treated with MTX with severe, active and progressive RA (early RA). Treating the disease at this critical early phase, within two years after diagnosis, may prevent irreversible damage to joints and long-term disability. (Source: Roche Investor Update)
Source: Roche Investor Update - July 28, 2014 Category: Pharmaceuticals Source Type: news

EU's CHMP Endorses New Indications for 2 Arthritis Drugs EU's CHMP Endorses New Indications for 2 Arthritis Drugs
The committee recommends tocilizumab for severe rheumatoid arthritis in adults not previously treated with methotrexate and adalimumab for active enthesitis-related arthritis. International Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 25, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

The Role of the Circadian Clock in Rheumatoid ArthritisThe Role of the Circadian Clock in Rheumatoid Arthritis
Is rheumatoid arthritis regulated by the circadian clock? Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 25, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

NIH MedlinePlus Magazine Summer Issue Available
The Summer 2014 issue of NIH MedlinePlus the Magazine features information on treating cataracts, understanding rheumatoid arthritis (RA), screening for breast cancer, and The Children’s Inn at NIH turning 25. The cover features Amy Robach, who was diagnosed as the one of 1-in-8 women in America who will be affected by breast cancer in their […] (Source: NN/LM Middle Atlantic Region Blog)
Source: NN/LM Middle Atlantic Region Blog - July 18, 2014 Category: Databases & Libraries Authors: mjharvey Tags: Consumer Health Education News from NLM/NIH Outreach Source Type: news

Are Docs Adhering to Targeted Treatment in RA?Are Docs Adhering to Targeted Treatment in RA?
A new study follows up the BeSt study and looks at physician compliance with DAS-based treat-to-target strategies in rheumatoid arthritis. Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 18, 2014 Category: Consumer Health News Tags: Rheumatology Commentary Source Type: news

Mayo Clinic News Network — Headlines 7/17/14
https://www.youtube.com/watch?v=AWW9PIJPGgw Mayo Clinic News Network Headlines include: Rheumatoid arthritis patients with heart problems Stem cell research for ALS  Lung nodules Journalists: Video is available in the downloads. Click here for script. (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 17, 2014 Category: Databases & Libraries Source Type: news

FDA Clears Subcutaneous Methotrexate Injection (Rasuvo)FDA Clears Subcutaneous Methotrexate Injection (Rasuvo)
Rasuvo, delivered in an auto-injector, is approved for rheumatoid arthritis, polyarticular-course juvenile idiopathic arthritis and psoriasis and will be available in 10 dosage strengths. FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 16, 2014 Category: Consumer Health News Tags: Rheumatology News Alert Source Type: news

RHEUMATOID ARTHRITIS NOSODE (Atp (Adenosine Triphosphate Disodium), Malic Acid, Natrum Oxalaceticum, Riboflavinum, Apiolum, Cinnamic Acid, Dhea (Dehydroepiandrosterone), Streptococcus Viridans) Liquid [Deseret Biologicals, Inc.]
Updated Date: Jul 16, 2014 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - July 16, 2014 Category: Drugs & Pharmacology Source Type: news

Improving Trial Design and Predictability in Rheumatoid Arthritis With...
In this webinar, the presenters will discuss how to leverage time response modeling to optimize clinical trial design and better predict trial outcomes for Rheumatoid Arthritis (RA) and similar...(PRWeb July 15, 2014)Read the full story at http://www.prweb.com/releases/2014/07/prweb12012695.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - July 15, 2014 Category: Pharmaceuticals Source Type: news

Thursday consumer health tips
Should children be tested for high cholesterol? Pediatric white blood cell disorders Rheumatoid arthritis: Protect your health with vaccines Low potassium (hypokalemia) Can arthritis pain medications be harmful? (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 10, 2014 Category: Databases & Libraries Source Type: news